12 results
6-K
EX-99.2
OBSVF
ObsEva SA
13 Oct 21
ObsEva Announces Relationship with Syneos Health to Commercialize Linzagolix
9:27am
reasonably be expected to result in a Material Adverse Effect. Neither the Company nor any of its Subsidiaries is a party to a collective bargaining agreement
6-K/A
EX-99.2
OBSVF
ObsEva SA
13 Oct 21
ObsEva Announces Relationship with Syneos Health to Commercialize Linzagolix
5:24pm
in a Material Adverse Effect. Neither the Company nor any of its Subsidiaries is a party to a collective bargaining agreement, and the Company and its
6-K
EX-99.3
OBSVF
ObsEva SA
28 Jan 22
ObsEva Announces Corporate Updates
5:16pm
, which would reasonably be expected to result in a Material Adverse Effect. Neither the Company nor any of its Subsidiaries is a party to a collective … bargaining agreement, and the Company and its Subsidiaries believe that their relationships with their employees are good. To the knowledge
20-F
2016 FY
OBSVF
ObsEva SA
21 Apr 17
Annual report (foreign)
12:00am
. Employees.
As of December 31, 2016, we had 27 employees. None of our employees are represented by any collective bargaining agreements. We believe
10-K
2022 FY
OBSVF
ObsEva SA
31 Mar 23
Annual report
4:01pm
. In light of the Reorganization Plan and as of March 24, 2023, we had 6 full time employees. None are represented by labor unions or covered by collective … bargaining agreements. We consider our relations with our employees to be good.
Compensation and Benefits Program
Our compensation program is designed
DRS
7bi zyhscj
14 Oct 16
Draft registration statement
12:00am
F-1
q0yva30h720y4ugk
30 Dec 16
Registration statement (foreign)
12:00am
- Prev
- 1
- Next